REFERENCES
- Ballantyne J. The Disease and Deformities of the Fetus. Edinburgh: Oliver & Boyd, 1892.
- Braun T, Brauer M, Fuchs I, . Mirror syndrome: A systematic review of fetal associated conditions, maternal presentation and perinatal outcome. Fetal Diagn Ther 2010; 27(4):191–203.
- Chang YL, Chao AS, Hsu JJ, Chang SD, Soong YK. Selective fetocide reversed mirror syndrome in a dichorionic triplet pregnancy with severe twin–twin transfusion syndrome: A case report. Fetal Diagn Ther 2007; 22(6):428–430.
- Livingston JC, Malik KM, Crombleholme TM, Lim FY, Sibai BM. Mirror syndrome: A novel approach to therapy with fetal peritoneal-amniotic shunt. Obstet Gynecol 2007; 110(2 Pt 2):540–543.
- Midgley DY, Harding K. The Mirror syndrome. Eur J Obstet Gynecol Reprod Biol 2000; 88(2):201–202.
- Valsky DV, Daum H, Yagel S. Reversal of mirror syndrome after prenatal treatment of Diamond-Blackfan anemia. Prenat Diagn 2007; 27(12):1161–1164.
- Goeden AM, Worthington D. Spontaneous resolution of mirror syndrome. Obstet Gynecol 2005; 106(5 Pt 2):1183–1186.
- Duthie SJ, Walkinshaw SA. Parvovirus associated fetal hydrops: Reversal of pregnancy induced proteinuric hypertension by in utero fetal transfusion. Br J Obstet Gynaecol 1995; 102(12):1011–1013.
- Matsubara M, Nakata M, Murata S, Miwa I, Sumie M, Sugino N. Resolution of mirror syndrome after successful fetoscopic laser photocoagulation of communicating placental vessels in severe twin-twin transfusion syndrome. Prenat Diagn 2008; 28(12):1167–1168.
- Levine RJ, Maynard SE, Qian C, . Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350(7):672–683.
- Maynard SE, Min JY, Merchan J, . Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111(5):649–658.
- Rana S, Venkatesha S, DePaepe M, Chien EK, Paglia M, Karumanchi SA. Cytomegalovirus-induced mirror syndrome associated with elevated levels of circulating antiangiogenic factors. Obstet Gynecol 2007; 109(2 Pt2):549–552.
- Stepan H, Faber R. Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops. N Engl J Med 2006; 354(17):1857–1858.
- Espinoza J, Romero R, Nien JK, . A role of the anti-angiogenic factor sVEGFR-1 in the ‘mirror syndrome’ (Ballantyne’s syndrome). J Matern Fetal Neonatal Med 2006; 19(10):607–613.
- Levine RJ, Lam C, Qian C, . Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355(10):992–1005.
- Kanter D, Lindheimer MD, Wang E, . Angiogenic dysfunction in molar pregnancy. Am J Obstet Gynecol 2010; 202(2):184.e1–184.e5.
- Prefumo F, Pagani G, Fratelli N, Benigni A, Frusca T. Increased concentrations of antiangiogenic factors in mirror syndrome complicating twin-to-twin transfusion syndrome. Prenat Diagn 2010; 30(4):378–379.
- Stepan H, Faber R. Cytomegalovirus-induced mirror syndrome associated with elevated levels of angiogenic factors. Obstet Gynecol 2007; 109(5):1205–1206.
- Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science 1997; 277(5332):1669–1672.
- Nagamatsu T, Fujii T, Kusumi M, . Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: An implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 2004; 145(11):4838–4845.
- Karumanchi SA, Bdolah Y. Hypoxia and sFlt-1 in preeclampsia: The “chicken-and-egg” question. Endocrinology 2004; 145(11):4835–4837.
- Nevo O, Soleymanlou N, Wu Y, . Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol 2006; 291(4):R1085–R1093.
- Bdolah Y, Lam C, Rajakumar A, . Twin pregnancy and the risk of preeclampsia: Bigger placenta or relative ischemia? Am J Obstet Gynecol 2008; 198(4):428.e1–428.e6.